Sanqi Panax Notoginseng Injection- Shenzhen Longer Pharmaceutical Group Co., Ltd.

Shenzhen Longer Pharmaceutical Group Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

8/10

Indication:Applying to treatment of central retinal vein occlusion, hyphema, glaccoma, sequel, of cerebrovascular disease and virus hepatitis.
Specification:2mL:0.1g,2mL:0.2g,5mL:0.25g,10mL:0.25g
Dosage Form:Injection
Active Ingredients:Panax Notoginseng
Route of Administration:Intramuscular Injection
Shelf Life:2 years
Storage:Sealed
Package:ten ampoules per box
Place of Origin:China
Qualification:Chinese GMP

Applying to treatment of central retinal vein occlusion, hyphema, glaccoma, sequel, of cerebrovascular disease and virus hepatitis.